Boundless Bio, Inc.
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
BOLD$2.45-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
Balance Sheets
(in thousands, except par value data)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $17,868 | $26,587 |
| Short-term investments | 89,713 | 125,527 |
| Prepaid expenses and other current assets | 2,030 | 2,276 |
| Total current assets | 109,611 | 154,390 |
| Property and equipment, net | 3,216 | 4,321 |
| Right-of-use asset, net | 43,659 | 47,039 |
| Restricted cash | 560 | 560 |
| Other assets | 13 | 99 |
| Total assets | $157,059 | $206,409 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $6,727 | $5,354 |
| Accrued compensation | 2,643 | 2,781 |
| Lease liabilities, current portion | 3,167 | — |
| Total current liabilities | 12,537 | 8,135 |
| Lease liabilities, non-current | 45,868 | 47,632 |
| Total liabilities | 58,405 | 55,767 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 70,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value; 700,000 shares authorized, 22,407 shares issued and outstanding as of December 31, 2025; 700,000 shares authorized, 22,300 shares issued and outstanding as of December 31, 2024 | 2 | 2 |
| Additional paid-in-capital | 358,257 | 351,991 |
| Accumulated other comprehensive income | 64 | 121 |
| Accumulated deficit | (259,669) | (201,472) |
| Total stockholders’ equity | 98,654 | 150,642 |
| Total liabilities and stockholders’ equity | $157,059 | $206,409 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.